Magenta Medical lands $15 mln Series B
Magenta Medical, an Israeli medical device company focused on transcatheter heart failure therapy, has secured $15 million in Series B financing. The investors included Abiomed Inc, Pitango Venture Capital and Jafco Co.
28 September 2017•1 min read
